Browsing Tag
Dr. Reddy’s Laboratories
68 posts
Dr. Reddy’s Laboratories takes $620m gamble in Switzerland: Could this bold move dominate Europe?
Dr. Reddy’s Laboratories, the Indian pharmaceutical giant, has solidified its European ambitions with a monumental $620 million investment…
Dr. Reddy’s Laboratories secures key European endorsement for Rituximab biosimilar
In a significant development for the pharmaceutical industry, Dr. Reddy’s Laboratories Ltd. has received a positive opinion from…
Haleon to sell non-US nicotine replacement therapy portfolio to Dr. Reddy’s Laboratories
Haleon plc, a prominent player in the global healthcare market, has reached an agreement to sell its nicotine…
Dr. Reddy’s Laboratories launches DailyBloom IBS : India’s first integrated care plan for irritable bowel syndrome
Dr. Reddy’s Laboratories Ltd., a globally recognized pharmaceutical company, has unveiled DailyBloom IBS, marking a significant advancement in…
Dr. Reddy’s Laboratories launches migraine management wearable Nerivio in Germany
In an exciting development for migraine sufferers, Dr. Reddy’s Laboratories Ltd., a leader in the global pharmaceutical industry,…
Dr. Reddy’s Laboratories launches Versavo in UK, marking a milestone in cancer treatment
Dr. Reddy’s Laboratories Ltd., a leading global pharmaceutical company, has made significant strides in cancer treatment with the…
Dr. Reddy’s Laboratories expands wellness portfolio with MenoLabs acquisition
In a significant move within the healthcare industry, Dr. Reddy’s Laboratories Ltd. has announced the acquisition of the…
Coya Therapeutics partners with Dr. Reddy’s for neurodegenerative disease therapy development
Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company, has entered into a worldwide agreement with Dr. Reddy’s…
Dr. Reddy’s Laboratories introduces FDA-approved Nerivio for migraine management in India
Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, has announced the rollout of Nerivio in India. This state-of-the-art,…
Dr. Reddy’s Q2 FY24 financial results show 9% YoY revenue growth
Dr. Reddy’s Laboratories Ltd., an Indian pharma major, has unveiled its robust performance metrics for the Q2 FY24,…